Q&M eyes AI and tech investments for future growth
Firm's new AI platform meant to reduce the chance of misdiagnoses, recommend treatment plans in a more objective, transparent way.
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
A FLAW in the dental industry lies in how some dentists prescribe treatment plans simply because they prefer certain procedures. This comes at the expense of patients, said Ng Chin Siau, chief executive of Q&M Dental Group.
In 2018, Q&M established a company, EM2AI, to work on artificial intelligence (AI) projects that target pain points such as this. EM2AI is now preparing for clinical trials to get approval from the Health Sciences Authority for its AI platform, under the Class B medical device category.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Vietnam formalises new state leadership, redefining ‘four pillars’ power balance
